Cargando…
Sense and nonsense in sensors
Continuous subcutaneous glucose monitoring (CGM) is a developing technology in the treatment of diabetes mellitus. The first randomised controlled trials on its efficacy have been performed. In several studies, CGM lowered HbA(1c) in adult patients with suboptimally controlled type 1 diabetes mellit...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830625/ https://www.ncbi.nlm.nih.gov/pubmed/20225392 http://dx.doi.org/10.1007/s00125-009-1649-4 |